EXPE
93
2
MMM
42
5
KSS
26
-15
VRSN
58
2
WM
82
2
EW
46
3
UAL
83
-2
GILD
54
3
MHK
50
-5
BXP
60
5
UHS
62
6
ADT
50
2
EXPD
48
-5
GS
78
3
NRG
60
18
CMS
64
4
NWSA
63
-4
GWW
76
2
SLB
53
-3
PCG
93
4
EXPE
93
2
MMM
42
5
KSS
26
-15
VRSN
58
2
WM
82
2
EW
46
3
UAL
83
-2
GILD
54
3
MHK
50
-5
BXP
60
5
UHS
62
6
ADT
50
2
EXPD
48
-5
GS
78
3
NRG
60
18
CMS
64
4
NWSA
63
-4
GWW
76
2
SLB
53
-3
PCG
93
4
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

TAK
Takeda Pharmaceutical

Last Price:
13.45
Seasonality Move:
5.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Takeda Pharmaceutical Price Quote

$13.45
+0.01 (+-0.3%)
(Updated: November 27, 2024 at 4:42 AM ET)

Takeda Pharmaceutical Key Stats

Sell
24
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.38 - $13.47
52-week range:
$12.58 - $15.08
Dividend yield:
4.55%
P/E ratio:
42.55
P/S ratio:
1.42
P/B ratio:
0.88%
Volume:
964.7K
Avg. volume:
1.7M
1-year change:
-4.27%
Market cap:
$42.6B
Revenue:
$29.5B
EPS:
$0.6

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $6B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $306.8M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 2.37%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1.91%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 4.01%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.64% 6.41%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.11
Upside from Last Price: 19.87%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    195M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders